SANGAMO THERAPEUTICS, INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Sangamo Therapeutics, Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Sangamo Therapeutics, Inc Entity Common Stock, Shares Outstanding for the quarter ending November 7, 2024 was 209M shares, a 17.6% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 209M +31.3M +17.6% Nov 7, 2024 10-Q 2024-11-12
Q2 2024 208M +31.1M +17.6% Aug 2, 2024 10-Q 2024-08-06
Q1 2024 179M +7.08M +4.12% Mar 8, 2024 10-K 2024-03-13
Q3 2023 177M +13.5M +8.22% Oct 30, 2023 10-Q 2023-11-01
Q2 2023 177M +20.6M +13.1% Aug 4, 2023 10-Q 2023-08-08
Q1 2023 172M +25.1M +17.1% May 4, 2023 10-Q 2023-05-08
Q3 2022 164M +18.2M +12.5% Oct 31, 2022 10-Q 2022-11-03
Q2 2022 157M +11.2M +7.72% Aug 1, 2022 10-Q 2022-08-04
Q1 2022 147M +2.81M +1.95% May 2, 2022 10-Q 2022-05-05
Q3 2021 146M +4.23M +2.99% Nov 1, 2021 10-Q 2021-11-04
Q2 2021 145M +4.35M +3.09% Aug 2, 2021 10-Q 2021-08-05
Q1 2021 144M +3M +2.13% Apr 30, 2021 10-Q 2021-05-04
Q3 2020 141M +25.5M +22% Oct 30, 2020 10-Q 2020-11-04
Q2 2020 141M +25.3M +21.9% Aug 3, 2020 10-Q 2020-08-05
Q1 2020 141M +25.5M +22.1% May 5, 2020 10-Q 2020-05-11
Q3 2019 116M +13.8M +13.6% Nov 1, 2019 10-Q 2019-11-06
Q2 2019 116M +14M +13.8% Aug 2, 2019 10-Q 2019-08-07
Q1 2019 115M +13.9M +13.7% May 3, 2019 10-Q 2019-05-08
Q3 2018 102M +17.6M +20.8% Nov 1, 2018 10-Q 2018-11-08
Q2 2018 102M +18.1M +21.6% Aug 1, 2018 10-Q 2018-08-08
Q1 2018 101M +29.6M +41.1% May 1, 2018 10-Q 2018-05-10
Q3 2017 84.5M +13.9M +19.7% Nov 3, 2017 10-Q 2017-11-09
Q2 2017 83.6M +13M +18.4% Jul 31, 2017 10-Q 2017-08-09
Q1 2017 71.9M +1.45M +2.05% May 5, 2017 10-Q 2017-05-10
Q3 2016 70.6M +577K +0.82% Oct 24, 2016 10-Q 2016-10-27
Q2 2016 70.6M +757K +1.08% Aug 1, 2016 10-Q 2016-08-04
Q1 2016 70.5M May 2, 2016 10-Q 2016-05-05
Q4 2015 70.4M +1.2M +1.73% Feb 1, 2016 10-K 2016-02-18
Q3 2015 70M +1.64M +2.4% Oct 26, 2015 10-Q 2015-10-30
Q2 2015 69.9M +1.7M +2.49% Jul 31, 2015 10-Q 2015-08-06
Q4 2014 69.2M +6.43M +10.3% Feb 1, 2015 10-K 2015-02-25
Q3 2014 68.4M +6.61M +10.7% Oct 22, 2014 10-Q 2014-10-28
Q2 2014 68.2M +14.1M +26% Jul 23, 2014 10-Q 2014-07-29
Q1 2014 69.6M +15.8M +29.5% Apr 24, 2014 10-Q 2015-04-28
Q4 2013 62.7M +9.38M +17.6% Feb 1, 2014 10-K 2014-02-24
Q3 2013 61.8M +8.81M +16.6% Oct 31, 2013 10-Q 2013-11-04
Q2 2013 54.1M +1.36M +2.58% Jul 31, 2013 10-Q 2013-08-02
Q1 2013 53.7M +1.16M +2.21% Apr 30, 2013 10-Q 2013-05-09
Q4 2012 53.4M +799K +1.52% Feb 1, 2013 10-K 2013-02-26
Q3 2012 53M +517K +0.99% Oct 31, 2012 10-Q 2012-11-02
Q2 2012 52.7M +281K +0.54% Jul 31, 2012 10-Q 2012-08-03
Q1 2012 52.6M Apr 30, 2012 10-Q 2012-05-07
Q4 2011 52.6M Feb 1, 2012 10-K 2012-02-23
Q3 2011 52.5M Oct 31, 2011 10-Q 2011-11-04
Q2 2011 52.5M Jul 29, 2011 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.